Efficient Funding of Chemotherapy (EFC) Review - Interim Report

Page last updated: 5 September 2022

The Efficient Funding of Chemotherapy (EFC) Review seeks to investigate current processes involved in the production, distribution and access of chemotherapy and other medicines used for the treatment of cancer, that are provided through the Pharmaceutical Benefits Scheme (PBS) Section 100 EFC Program.

The EFC Review Interim Report, published by the Department of Health and Aged Care, is now available for feedback and comments via Consultation Hub.

Submissions will close at 11.59PM AEDT on 28 October 2022.